These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 36201204)
1. Novel Therapies on the Horizon of Hypertension Management. Blazek O; Bakris GL Am J Hypertens; 2023 Feb; 36(2):73-81. PubMed ID: 36201204 [TBL] [Abstract][Full Text] [Related]
2. New approaches in the treatment of hypertension. Oparil S; Schmieder RE Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291 [TBL] [Abstract][Full Text] [Related]
8. Emerging Drug Classes and Their Potential Use in Hypertension. Azizi M; Rossignol P; Hulot JS Hypertension; 2019 Nov; 74(5):1075-1083. PubMed ID: 31495277 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of resistant hypertension: state of the art. Wei FF; Zhang ZY; Huang QF; Staessen JA Nat Rev Nephrol; 2018 Jul; 14(7):428-441. PubMed ID: 29700488 [TBL] [Abstract][Full Text] [Related]
15. Novel and nonpharmacologic approaches to cardio-protection in hypertension. Donazzan L; Mahfoud F; Linz D; Ewen S; Ukena C; Böhm M Curr Hypertens Rep; 2014 May; 16(5):430. PubMed ID: 24633844 [TBL] [Abstract][Full Text] [Related]
16. New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension. Monge M; Lorthioir A; Bobrie G; Azizi M J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):285-9. PubMed ID: 24222656 [TBL] [Abstract][Full Text] [Related]
17. Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper. Habib GB; Basra SS J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):516-25. PubMed ID: 24790054 [TBL] [Abstract][Full Text] [Related]
18. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Carey RM; Calhoun DA; Bakris GL; Brook RD; Daugherty SL; Dennison-Himmelfarb CR; Egan BM; Flack JM; Gidding SS; Judd E; Lackland DT; Laffer CL; Newton-Cheh C; Smith SM; Taler SJ; Textor SC; Turan TN; White WB; Hypertension; 2018 Nov; 72(5):e53-e90. PubMed ID: 30354828 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology, prognosis, and treatment of resistant hypertension. Smith SM Pharmacotherapy; 2013 Oct; 33(10):1071-86. PubMed ID: 23722533 [TBL] [Abstract][Full Text] [Related]
20. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]